Rhenman & Partners Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.44M | Hold |
|
|||||
|
2025
Q1 | $4.19M | Sell |
|
|||||
|
2024
Q4 | $7.02M | Sell |
|
|||||
|
2024
Q3 | $9.53M | Sell |
|
|||||
|
2024
Q2 | $10.7M | Hold |
|
|||||
|
2024
Q1 | $13.8M | Buy |
|
|||||
|
2023
Q4 | $12.5M | Sell |
|
|||||
|
2023
Q3 | $5.89M | Hold |
|
|||||
|
2023
Q2 | $6.52M | Sell |
|
|||||
|
2023
Q1 | $7.01M | Sell |
|
|||||
|
2022
Q4 | $9.91M | Buy |
|
|||||
|
2022
Q3 | $9.17M | Sell |
|
|||||
|
2022
Q2 | $9.04M | Sell |
|
|||||
|
2022
Q1 | $10.9M | Buy |
|
|||||
|
2021
Q4 | $6.84M | Buy |
|